A One-In-A-Billion Chance : The Transformative Effect of Stan Lee and Spider-Man on American Popular Culture

The body of research from scholarly sources on the history of comic books contends that Stan Lee’s original run of The Amazing Spider-Man influenced American culture in a generic sense, but little has been written on the specific ways the comic influenced popular culture. This paper details four specific ways that Stan Lee’s Spider-Man influenced American popular culture during the tumultuous decade of the 1960’s. The comic redefined the modern American hero by making a flawed character, with a tenuous grasp on the moral high ground, the protagonist. It also affirmed the newly established teenage identity in American society by depicting a teenager as a full-fledged superhero, not a sidekick. Stan Lee’s Spider-Man also pioneered the use of the comic book medium as a platform to discuss contentious national issues during the 1960’s, including civil rights, drug abuse, and the Vietnam War. Finally, the title undermined censorship in the comic book industry by daring to defy the Comics Code Authority’s prohibition on depictions of drug use. Through these four groundbreaking efforts Stan Lee and Spider-Man earned their place in the pantheon of American popular culture icons and shaped the course of American culture for decades to come

The Impact of Victor Hugo’s Writings from Exile upon the French Second Empire

When Louis-Napoleon staged a coup d’état and overthrew the French Second Republic in 1851, renowned French author and republican politician Victor Hugo escaped into exile on the British isle of Guernsey. He remained in exile until the republic was reestablished in 1870. This thesis examines the works he published during the period, including the political pamphlet Napoléon le Petit, two poetry collections—Les Chȃtiments and Les Contemplations—and his magnum opus novel Les Misérables. Victor Hugo used these writings to remain politically active, even while in exile, by consistently promoting the cause of republicanism in France. His politically charged writings helped shape the course of French politics in the 1860s, ultimately contributing to the fall of the French Second Empire and the restoration of the Republic

The effect of hot and cold drinks on thermoregulation, perception and performance: the role of the gut in thermoreception

Purpose. Hot compared to cold drinks alter sweating responses during very low intensity exercise in temperate conditions. The thermoregulatory, perceptual and performance effects of hot compared to cold drinks in hot, dry conditions during high-intensity exercise have not been examined. Method. Ten participants (mean ± SD characteristics age 25 ± 5 years, height 1.81 ± 0.07 m, body mass 73.5 ± 10.6 kg, maximal power output (PMax) 350 ± 41 W). completed two conditions where they drank four boluses (ingested at -9, 15, 30 & 45 minutes respectively) of 3.2 mL.kg-1 (~960 mL total) of either a COLD (5.3°C) or a HOT drink (49.0°C), which were contrasted to a no drink CONTROL. They cycled for 60-minutes (55% PMax in hot (34.4°C) dry (34% RH) ambient conditions followed by a test to exhaustion (TTE; 80% PMax). The thermoregulatory, performance and perceptual implications of drink temperature were measured. Results. TTE was worse in the CONTROL (170 ± 132 s) than the COLD drink (371 ± 272 s; p = .021) and HOT drink conditions (367 ± 301 s; p = .038) which were not different (p = .965). Sweat responses (i.e. reflex changes in mean skin temperature (Tmsk) and galvanic skin conductance) indicated transient reductions in sweating response after COLD drink ingestion. The COLD drink improved thermal comfort beyond the transient changes in sweating. Conclusion. Only COLD drink ingestion changed thermoregulation but improved perceptual response. Accordingly, we conclude a role for gut thermoreception in thermal perception during exercise in hot, dry conditions

Fire Resistant Material

The present invention relates to inorganic-organic hybrids (IOHs), methods for their preparation and their use as fire resistant materials or components of fire resistant materials. More specifically, the invention relates to polyamide fire resistant formulations containing IOHs which have application in the production of fire resistant articles or parts thereof for use in the transportation, building, construction and electrical or optical industries

Efficacy and safety of tiotropium Respimat® SMI in COPD in two 1-year randomized studies

Two 1-year studies evaluated the long-term efficacy and safety of tiotropium 5 or 10 μg versus placebo, inhaled via the Respimat® Soft Mist™ Inhaler (SMI). The two studies were combined and had 4 co-primary endpoints (trough FEV1 response, Mahler Transition Dyspnea Index [TDI] and St George’s Respiratory Questionnaire scores all at week 48, and COPD exacerbations per patient-year). A total of 1990 patients with COPD participated (mean FEV1: 1.09 L). The mean trough FEV1 response of tiotropium 5 or 10 μg relative to placebo was 127 or 150 mL, respectively (both P < 0.0001). The COPD exacerbation rate was significantly lower with tiotropium 5 μg (RR = 0.78; P = 0.002) and tiotropium 10 μg (RR = 0.73; P = 0.0008); the health-related quality of life and Mahler TDI co-primary endpoints were significantly improved with both doses (both P < 0.0001). Adverse events were generally balanced except anticholinergic class effects, which were more frequent with active treatment. Fatal events occurred in 2.4% (5 μg), 2.7% (10 μg), and 1.6% (placebo) of patients; these differences were not significant. Tiotropium Respimat® SMI 5 μg demonstrated sustained improvements in patients with COPD relative to placebo and similar to the 10 μg dose but with a lower frequency of anticholinergic adverse events

Ic‐P‐204: The Relationship Between Tau Pet And Other Ad Biomarkers In Autosomal Dominant Alzheimer Disease

Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/152660/1/alzjjalz2018062271.pd

The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia

PURPOSE: Failure to respond to induction chemotherapy portends a poor outcome in childhood acute lymphoblastic leukemia (ALL) and is more frequent in T-cell ALL (T-ALL) than B-cell ALL. We aimed to address the limited understanding of clinical and genetic factors that influence outcome in a cohort of patients with T-ALL induction failure (IF).METHODS: We studied all cases of T-ALL IF on two consecutive multinational randomized trials, UKALL2003 and UKALL2011, to define risk factors, treatment, and outcomes. We performed multiomic profiling to characterize the genomic landscape.RESULTS: IF occurred in 10.3% of cases and was significantly associated with increasing age, occurring in 20% of patients age 16 years and older. Five-year overall survival (OS) rates were 52.1% in IF and 90.2% in responsive patients (P &lt; .001). Despite increased use of nelarabine-based chemotherapy consolidated by hematopoietic stem-cell transplant in UKALL2011, there was no improvement in outcome. Persistent end-of-consolidation molecular residual disease resulted in a significantly worse outcome (5-year OS, 14.3% v 68.5%; HR, 4.10; 95% CI, 1.35 to 12.45; P = .0071). Genomic profiling revealed a heterogeneous picture with 25 different initiating lesions converging on 10 subtype-defining genes. There was a remarkable abundance of TAL1 noncoding lesions, associated with a dismal outcome (5-year OS, 12.5%). Combining TAL1 lesions with mutations in the MYC and RAS pathways produces a genetic stratifier that identifies patients highly likely to fail conventional therapy (5-year OS, 23.1% v 86.4%; HR, 6.84; 95% CI, 2.78 to 16.78; P &lt; .0001) and who should therefore be considered for experimental agents.CONCLUSION: The outcome of IF in T-ALL remains poor with current therapy. The lack of a unifying genetic driver suggests alternative approaches, particularly using immunotherapy, are urgently needed.</p

The Clinicogenomic Landscape of Induction Failure in Childhood and Young Adult T-Cell Acute Lymphoblastic Leukemia

PURPOSE: Failure to respond to induction chemotherapy portends a poor outcome in childhood acute lymphoblastic leukemia (ALL) and is more frequent in T-cell ALL (T-ALL) than B-cell ALL. We aimed to address the limited understanding of clinical and genetic factors that influence outcome in a cohort of patients with T-ALL induction failure (IF). METHODS: We studied all cases of T-ALL IF on two consecutive multinational randomized trials, UKALL2003 and UKALL2011, to define risk factors, treatment, and outcomes. We performed multiomic profiling to characterize the genomic landscape. RESULTS: IF occurred in 10.3% of cases and was significantly associated with increasing age, occurring in 20% of patients age 16 years and older. Five-year overall survival (OS) rates were 52.1% in IF and 90.2% in responsive patients (P < .001). Despite increased use of nelarabine-based chemotherapy consolidated by hematopoietic stem-cell transplant in UKALL2011, there was no improvement in outcome. Persistent end-of-consolidation molecular residual disease resulted in a significantly worse outcome (5-year OS, 14.3% v 68.5%; HR, 4.10; 95% CI, 1.35 to 12.45; P = .0071). Genomic profiling revealed a heterogeneous picture with 25 different initiating lesions converging on 10 subtype-defining genes. There was a remarkable abundance of TAL1 noncoding lesions, associated with a dismal outcome (5-year OS, 12.5%). Combining TAL1 lesions with mutations in the MYC and RAS pathways produces a genetic stratifier that identifies patients highly likely to fail conventional therapy (5-year OS, 23.1% v 86.4%; HR, 6.84; 95% CI, 2.78 to 16.78; P < .0001) and who should therefore be considered for experimental agents. CONCLUSION: The outcome of IF in T-ALL remains poor with current therapy. The lack of a unifying genetic driver suggests alternative approaches, particularly using immunotherapy, are urgently needed

Reductions in commuting mobility correlate with geographic differences in SARS-CoV-2 prevalence in New York City.

SARS-CoV-2-related mortality and hospitalizations differ substantially between New York City neighborhoods. Mitigation efforts require knowing the extent to which these disparities reflect differences in prevalence and understanding the associated drivers. Here, we report the prevalence of SARS-CoV-2 in New York City boroughs inferred using tests administered to 1,746 pregnant women hospitalized for delivery between March 22nd and May 3rd, 2020. We also assess the relationship between prevalence and commuting-style movements into and out of each borough. Prevalence ranged from 11.3% (95% credible interval [8.9%, 13.9%]) in Manhattan to 26.0% (15.3%, 38.9%) in South Queens, with an estimated city-wide prevalence of 15.6% (13.9%, 17.4%). Prevalence was lowest in boroughs with the greatest reductions in morning movements out of and evening movements into the borough (Pearson R = -0.88 [-0.52, -0.99]). Widespread testing is needed to further specify disparities in prevalence and assess the risk of future outbreaks